Study of the efficacy of topically applied cyclosporinsolution on psoriatic nails.
Completed
- Conditions
- Psoriasis of the vingernails.
- Registration Number
- NL-OMON25326
- Lead Sponsor
- Erasmus MC
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1. Clinical diagnosis of psoriasis of fingernails in both hands;
2. In cases of oral treatment with methotrexate, prednisone or fumarates, the dose of medication before the start has to be constant for 8 weeks and it may be reasonably expected that the dose shall not be altered during the treatment phase of the study;
Exclusion Criteria
1. Systemic treatment with cyclosporine or a biological agent (efaluzimab, etanercept or related medication);
2. Change of oral medication 8 weeks before the start of the trial;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method APSI scores.
- Secondary Outcome Measures
Name Time Method Prevention? Does the NAPSI correlate with patientsatisfaction?